Severe acute respiratory syndrome-associated coronavirus IVDs

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

下载 公众评估报告 (PAR)
19-04-2022

可用日期:

MD Solutions Australasia Pty Ltd

类:

Class 3

厂商:

Philosys Co Ltd 28-5 Gwangwol-gil Okgu-Eup, Gunsan-si, Jeollabuk-do, 54172 Korea - Republic of

治疗领域:

CT772 - Severe acute respiratory syndrome-associated coronavirus IVDs

疗效迹象:

Intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19, for self-testing by lay persons (saliva).

授权状态:

A

授权日期:

2022-02-10